de Groof, E Joline <br/><br/>
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial.  [electronic resource] 

 -  Gut  10 2019 
 - 1774-1780 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2018-317539  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cecum--surgery<br/>Colectomy--economics<br/>Cost-Benefit Analysis<br/>Crohn Disease--economics<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Agents--economics<br/>Health Care Costs<br/>Humans<br/>Ileitis--diagnosis<br/>Ileum--surgery<br/>Infliximab--economics<br/>Laparoscopy--economics<br/>Male<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult